Skip to Content
CL29309

Lorlatinib

Catalog Number: CL29309 , CAS Number: 1454846-35-5

Package Size Price Qty
1mg $ 13.50
5mg $ 24.30
25mg $ 42.30
100mg $ 74.52
250mg $ 143.52
1g $ 466.24
5g $ 1,666.56
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Description / Application

Lorlatinib is a cyclic ether that is 16,17-dihydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-15(10H)-one substituted by methyl groups at positions 2 and 10R, and by cyano, amino and fluoro groups at positions 3, 7 and 12 respectively. It is a small molecule inhibitor of ALK and ROS1 kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer. It has a role as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a nitrile, a member of benzamides, a member of pyrazoles, an aromatic ether, a cyclic ether, an organic heterotetracyclic compound, an aminopyridine, an azamacrocycle and a member of monofluorobenzenes.

Identities
Molecular FormulaC21H19FN6O2
Molecular Weight406.4
MFCDMFCD28144520
Safety
Pictograms
Signal WordWarning
Hazard StatementsH315;H319;H335
Precautionary StatementsP261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501